FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4281687622> ?p ?o ?g. }

• W4281687622 endingPage "154216" @default.
• W4281687622 startingPage "154216" @default.
• W4281687622 abstract "Activation of immune system in rheumatoid arthritis (RA) consumes amount of energy, and the energy metabolic signals may be a potential target for RA therapy. Baihu-Guizhi decoction (BHGZD) achieves satisfactory therapeutic effects in RA in clinics by recovering the adjacent articular cartilage and bone destruction, and abnormal articular temperature. However, its pharmacological material basis and molecular mechanisms have not been fully elucidated.This study focused on exploring the potential acting mechanism of BHGZD against RA, and identifying its main bioactive compounds (BACs) of the combination of mangiferin and glycyrrhizic acid.Key putative targets of BHGZD acting on adjuvant-induced arthritis (AIA)-M rats were screened by the transcriptomic profiling of the whole blood cells and synovium tissues collected from rats in normal control, AIA-M model and AIA-M-BHGZD treatment groups. Then, BACs of BHGZD against RA were identified using Ultra Performance Liquid Chromatography-Mass spectrum/Mass spectrum, molecular docking, surface plasmon resonance and pharmacokinetic analysis. In vivo experiments based on AIA-M rats and in vitro experiments based on 3T3-L1 preadipocytes were performed to verify the pharmacological effects of BACs against RA and the corresponding mechanisms.PKA-ADCY5-PPARγ-PGC 1α-UCP1-PRDM16 signal axis was demonstrated to be the candidate targets of BHGZD against RA and was involved in maintaining the balance of thermogenesis and energy metabolism, according to the transcriptional regulatory network analysis based on herbs-putative targets-disease interaction network. Then, mangiferin from Rhizoma Anemarrhenae and glycyrrhizic acid from Radix Glycytthizae were identified as the main BACs of BHGZD against RA due to their highly accumulation in the blood in vivo, strong binding affinities with the two candidate targets of BHGZD against RA-ADCY5 and PPARγ, as well as the in vivo and in vitro strong regulation effects on energy metabolism disturbance.These findings offer evidence that the combination of mangiferin and glycyrrhizic acid from BHGZD may be a promising candidate drug for RA therapy, and also provide an important reference for the development and modernization of traditional Chinese formulae." @default.
• W4281687622 created "2022-06-13" @default.
• W4281687622 creator A5002145670 @default.
• W4281687622 creator A5012628393 @default.
• W4281687622 creator A5018077929 @default.
• W4281687622 creator A5018709776 @default.
• W4281687622 creator A5046225712 @default.
• W4281687622 creator A5049410725 @default.
• W4281687622 creator A5051027744 @default.
• W4281687622 creator A5052308910 @default.
• W4281687622 creator A5065704094 @default.
• W4281687622 creator A5079115940 @default.
• W4281687622 creator A5081239726 @default.
• W4281687622 creator A5082259400 @default.
• W4281687622 date "2022-09-01" @default.
• W4281687622 modified "2023-10-16" @default.
• W4281687622 title "A promising drug combination of mangiferin and glycyrrhizic acid ameliorates disease severity of rheumatoid arthritis by reversing the disturbance of thermogenesis and energy metabolism" @default.
• W4281687622 cites W1817799409 @default.
• W4281687622 cites W1966671871 @default.
• W4281687622 cites W1977461643 @default.
• W4281687622 cites W1988758413 @default.
• W4281687622 cites W2077889896 @default.
• W4281687622 cites W2086107460 @default.
• W4281687622 cites W2096173332 @default.
• W4281687622 cites W2103769668 @default.
• W4281687622 cites W2163419774 @default.
• W4281687622 cites W2296538988 @default.
• W4281687622 cites W2424659657 @default.
• W4281687622 cites W2600768542 @default.
• W4281687622 cites W2607904812 @default.
• W4281687622 cites W2613535326 @default.
• W4281687622 cites W2622000437 @default.
• W4281687622 cites W2623617647 @default.
• W4281687622 cites W2755954973 @default.
• W4281687622 cites W2757001841 @default.
• W4281687622 cites W2898468989 @default.
• W4281687622 cites W2920950273 @default.
• W4281687622 cites W2944322830 @default.
• W4281687622 cites W2954541576 @default.
• W4281687622 cites W2996833068 @default.
• W4281687622 cites W3003365788 @default.
• W4281687622 cites W3013762759 @default.
• W4281687622 cites W3014146563 @default.
• W4281687622 cites W3016195349 @default.
• W4281687622 cites W3118505746 @default.
• W4281687622 cites W3131778757 @default.
• W4281687622 cites W3175495335 @default.
• W4281687622 cites W3216103745 @default.
• W4281687622 cites W4283212097 @default.
• W4281687622 doi "https://doi.org/10.1016/j.phymed.2022.154216" @default.
• W4281687622 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35749826" @default.
• W4281687622 hasPublicationYear "2022" @default.
• W4281687622 type Work @default.
• W4281687622 citedByCount "3" @default.
• W4281687622 countsByYear W42816876222023 @default.
• W4281687622 crossrefType "journal-article" @default.
• W4281687622 hasAuthorship W4281687622A5002145670 @default.
• W4281687622 hasAuthorship W4281687622A5012628393 @default.
• W4281687622 hasAuthorship W4281687622A5018077929 @default.
• W4281687622 hasAuthorship W4281687622A5018709776 @default.
• W4281687622 hasAuthorship W4281687622A5046225712 @default.
• W4281687622 hasAuthorship W4281687622A5049410725 @default.
• W4281687622 hasAuthorship W4281687622A5051027744 @default.
• W4281687622 hasAuthorship W4281687622A5052308910 @default.
• W4281687622 hasAuthorship W4281687622A5065704094 @default.
• W4281687622 hasAuthorship W4281687622A5079115940 @default.
• W4281687622 hasAuthorship W4281687622A5081239726 @default.
• W4281687622 hasAuthorship W4281687622A5082259400 @default.
• W4281687622 hasBestOaLocation W42816876221 @default.
• W4281687622 hasConcept C126322002 @default.
• W4281687622 hasConcept C150903083 @default.
• W4281687622 hasConcept C151279926 @default.
• W4281687622 hasConcept C171089720 @default.
• W4281687622 hasConcept C185592680 @default.
• W4281687622 hasConcept C207001950 @default.
• W4281687622 hasConcept C2777077863 @default.
• W4281687622 hasConcept C2777575956 @default.
• W4281687622 hasConcept C2777781930 @default.
• W4281687622 hasConcept C55493867 @default.
• W4281687622 hasConcept C71924100 @default.
• W4281687622 hasConcept C86803240 @default.
• W4281687622 hasConcept C98274493 @default.
• W4281687622 hasConceptScore W4281687622C126322002 @default.
• W4281687622 hasConceptScore W4281687622C150903083 @default.
• W4281687622 hasConceptScore W4281687622C151279926 @default.
• W4281687622 hasConceptScore W4281687622C171089720 @default.
• W4281687622 hasConceptScore W4281687622C185592680 @default.
• W4281687622 hasConceptScore W4281687622C207001950 @default.
• W4281687622 hasConceptScore W4281687622C2777077863 @default.
• W4281687622 hasConceptScore W4281687622C2777575956 @default.
• W4281687622 hasConceptScore W4281687622C2777781930 @default.
• W4281687622 hasConceptScore W4281687622C55493867 @default.
• W4281687622 hasConceptScore W4281687622C71924100 @default.
• W4281687622 hasConceptScore W4281687622C86803240 @default.
• W4281687622 hasConceptScore W4281687622C98274493 @default.
• W4281687622 hasLocation W42816876221 @default.
• W4281687622 hasLocation W42816876222 @default.
• W4281687622 hasOpenAccess W4281687622 @default.

• next